Related Experiment Video
Updated: Jun 28, 2026

Protection of H9c2 Myocardial Cells from Oxidative Stress by Crocetin via PINK1/Parkin Pathway-Mediated Mitophagy
Published on: May 26, 2023
Nicorandil protects ATP-sensitive potassium channels against oxidation-induced dysfunction in cardiomyocytes of aging
Stéphanie Raveaud1, Jean Verdetti, Gilles Faury
1Université Joseph Fourier, Grenoble, France.
Abstract:
ATP-sensitive potassium channels (K(ATP) channels) regulate vascular tone and cardiac contraction through their action on the membrane potential of smooth muscle cells and cardiomyocytes. Because aging and diseases alter K(ATP) channel activity, many pharmacological treatments aimed at improving their function, therefore cardiovascular function, have been evaluated. Nicorandil, a K(ATP) channel opener, nitric oxide donor and antioxidant, is used as a treatment of angina pectoris and induces vasodilation, blood pressure decrease and cardioprotection in aging as well as after ischemia-reperfusion. Here, using the patch-clamp technique, we have studied the effect a chronic low dose of nicorandil (0.1 mg/kg per day for 2 months), on the activity of cardiomyocyte K(ATP) channels as a function of age, in newborn, 4-, 12- and 24-month old rats. Nicorandil exerted an anti-oxidant and protective action on cardiomyocyte K(ATP) channels, especially in aged animals, leading to restoration of a normal channel activity. These findings could justify further therapeutical applications.
Insights
Nicorandil, a K(ATP) channel opener, protects aged heart cells by restoring normal ATP-sensitive potassium channel activity. This antioxidant effect offers potential therapeutic benefits for cardiovascular health in aging populations.
Area of Science:
- Cardiovascular Physiology
- Pharmacology
- Cellular Electrophysiology
Background:
- ATP-sensitive potassium channels (K(ATP) channels) are crucial for regulating vascular tone and cardiac function.
- Aging and disease impair K(ATP) channel activity, necessitating treatments to improve cardiovascular health.
- Nicorandil is a known K(ATP) channel opener with vasodilatory, antihypertensive, and cardioprotective properties.
Purpose of the Study:
- To investigate the chronic effects of a low dose of nicorandil on cardiomyocyte K(ATP) channel activity across different age groups.
- To assess nicorandil's protective and antioxidant actions on K(ATP) channels, particularly in aged cardiomyocytes.
Main Methods:
- Utilized the patch-clamp technique to record cardiomyocyte K(ATP) channel activity.
- Administered a chronic low dose of nicorandil (0.1 mg/kg/day for 2 months) to rats of varying ages (newborn, 4, 12, and 24 months).
Main Results:
- Nicorandil demonstrated antioxidant and protective effects on cardiomyocyte K(ATP) channels.
- These beneficial effects were most pronounced in aged animals, restoring normal channel activity.
- The findings suggest a mechanism for nicorandil's cardioprotective actions in aging.
Conclusions:
- Chronic low-dose nicorandil effectively protects cardiomyocyte K(ATP) channels, especially in aged hearts.
- Nicorandil's ability to restore normal channel function supports its therapeutic potential for age-related cardiovascular decline.
- Further research into nicorandil's applications for enhancing cardiovascular health in aging is warranted.
Related Concept Videos
Heart Failure Drugs: Inotropic Agents
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class III Agents as Potassium Channel Blockers
Pharmacodynamics in Geriatric Patients: Effects of Age
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Electron Transport Chain: Complex I and II
ROS generation is regulated and maintained at moderate levels necessary...
